Cellular Dynamics International |
Thomas Novak |
hiPSC Derivation |
Generation and characterization of high-quality, footprint-free human induced pluripotent stem cell lines from 3,000 donors to investigate multigenic diseases |
$16,000,000 |
FUJIFILM Cellular Dynamics |
Deborah Requesens |
hPSC Repository |
The CIRM Human Pluripotent Stem Cell Biorepository – A Resource for Safe Storage and Distribution of High Quality iPSCs |
$9,942,175 |
Stanford University |
Joachim Hallmayer |
Tissue Collection for Disease Modeling |
Induced pluripotent stem cells from children with autism spectrum disorders |
$530,265 |
University of California, Los Angeles |
Brigitte Gomperts |
Tissue Collection for Disease Modeling |
Using human induced pluripotent stem cells to improve our understanding of Idiopathic Pulmonary Fibrosis |
$811,231 |
Stanford University |
Joseph Wu |
Tissue Collection for Disease Modeling |
Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases |
$1,291,832 |
University of California, San Diego |
Kang Zhang |
Tissue Collection for Disease Modeling |
Generation of fibroblast cell lines in patients with common blinding eye diseases |
$1,034,425 |
University of California, Los Angeles |
Tatiana Segura |
Conference |
2013 Materials Research Society (MRS) Spring Meeting Symposium
"Design of Cell Instructive Materials" |
$4,000 |
City of Hope, Beckman Research Institute |
Fouad Kandeel |
Conference |
2013 Rachmiel Diabetes and Obesity Levine Symposium - Advances in Diabetes Research |
$27,750 |
University of California, San Diego |
Mana Parast |
New Faculty Physician Scientist |
Human pluripotent stem cell-based therapeutics for preeclampsia |
$2,974,750 |
University of California, San Francisco |
Ophir Klein |
New Faculty Physician Scientist |
Stem cell therapy for inflammatory bowel disease |
$3,019,013 |
University of California, San Francisco |
Jason Pomerantz |
New Faculty Physician Scientist |
Characterization of Human Skeletal Muscle Stem Cells for Clinical Application |
$2,959,014 |
University of California, Davis |
Emanual Maverakis |
New Faculty Physician Scientist |
Tunable hydrogels for therapeutic delivery of multipotent stem cells. |
$2,771,903 |
University of California, San Francisco |
Ann Zovein |
New Faculty Physician Scientist |
Human endothelial reprogramming for hematopoietic stem cell therapy. |
$2,197,683 |
University of California, Los Angeles |
Ali Nsair |
New Faculty Physician Scientist |
Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. |
$2,316,894 |
Stanford University |
Michelle Monje |
New Faculty Physician Scientist |
White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” |
$2,800,526 |
Children's Hospital of Los Angeles |
Tracy Grikscheit |
New Faculty Physician Scientist |
The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation |
$3,146,160 |
University of California, San Francisco |
Tippi MacKenzie |
New Faculty Physician Scientist |
In Utero Embryonic Stem Cell Transplantation to Treat Congenital Anomalies |
$2,661,742 |
Stanford University |
Alan Cheng |
New Faculty Physician Scientist |
Enhancing hair cell regeneration in mouse and human inner ear |
$3,088,525 |
Cedars-Sinai Medical Center |
Robert Baloh |
New Faculty Physician Scientist |
Human iPSC modeling and therapeutics for degenerative peripheral nerve disease |
$3,031,737 |
University of California, Los Angeles |
Reza Ardehali |
New Faculty Physician Scientist |
Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors in a large animal model |
$2,930,388 |
Children's Neurobiological Solutions (CNS) Foundation |
Alex Richmond |
Conference |
The Best Next Steps: Setting a Path for Advancing Pediatric Neurology |
$10,000 |
ViaCyte, Inc. |
Howard Foyt |
Strategic Partnership I |
Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes |
$9,475,070 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Conference |
California ALS Summit 2012 |
$6,825 |
Vitalant Research Institute |
Shibani Pati |
Conference |
Cell Therapies in Trauma and Critical Care: Barriers in Translation from Pre-clinical to Clinical Development |
$18,440 |
University of California, Davis |
Alice Tarantal |
Conference |
11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$16,850 |
Gladstone Institutes, J. David |
Deepak Srivastava |
Conference |
ISSCR - Roddenberry International Symposium on Cellular reprogramming |
$43,000 |
Research for Cure |
Marilyn Smith |
Conference |
Working 2 Walk Science & Advocacy Symposium |
$22,113 |
University of California, San Francisco |
Ophir Klein |
Conference |
Stem Cells Craniofacial Development and Disease |
$4,500 |
Sanford Consortium for Regenerative Medicine |
Lawrence Goldstein |
Conference |
The Sanford Consortium for Regenerative Medicine Symposium and the investor and Partnering Forum at Stem Cells on the Mesa |
$44,000 |
Stanford University |
Michael Cleary |
Basic Biology IV |
Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells |
$1,244,455 |
University of California, Davis |
Deborah Lieu |
Basic Biology IV |
Induction of Pluripotent Stem Cell-Derived Pacemaking Cells |
$1,333,689 |
City of Hope, Beckman Research Institute |
Yanhong Shi |
Basic Biology IV |
Modeling Alexander disease using patient-specific induced pluripotent stem cells |
$1,366,656 |
University of California, San Francisco |
Miguel Ramalho-Santos |
Basic Biology IV |
Genetic dissection of human cellular reprogramming to pluripotency |
$1,184,883 |
University of California, San Diego |
Maike Sander |
Basic Biology IV |
Deciphering transcriptional control of pancreatic beta-cell maturation in vitro |
$1,258,560 |
Buck Institute for Age Research |
Deepak Lamba |
Basic Biology IV |
3D Modeling of Retina using Polymer Scaffolds for Understanding Disease Pathogenesis |
$1,212,553 |
Sanford Burnham Prebys Medical Discovery Institute |
Huei-sheng Chen |
Basic Biology IV |
Studying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells |
$1,579,250 |
University of California, San Francisco |
Jeremy Reiter |
Basic Biology IV |
Modeling disease in human embryonic stem cells using new genetic tools |
$1,387,800 |
Stanford University |
Howard Chang |
Basic Biology IV |
Long noncoding RNAs for pluripotency and cell fate commitment |
$1,386,627 |
Stanford University |
Alexander Dunn |
Basic Biology IV |
Role of mechanical signaling in stem cell self-renewal and differentiation |
$1,062,998 |
Gladstone Institutes, J. David |
Steven Finkbeiner |
Basic Biology IV |
Common molecular mechanisms in neurodegenerative diseases using patient based iPSC neurons |
$1,395,184 |
University of California, San Diego |
George Sen |
Basic Biology IV |
Regulation of Epidermal Self-Renewal and Differentiation by Histone and DNA Demethylases. |
$1,080,000 |
Gladstone Institutes, J. David |
Benoit Bruneau |
Basic Biology IV |
Epigenetic regulation of human cardiac differentiation |
$1,568,148 |
University of California, Los Angeles |
Kathrin Plath |
Basic Biology IV |
Understanding the status of the X chromosomes in human ESCs and preimplantation embryos |
$1,382,400 |
University of California, San Diego |
Miles Wilkinson |
Basic Biology IV |
Role of the NMD RNA Decay Pathway in Maintaining the Stem-Like State |
$1,360,450 |
Gladstone Institutes, J. David |
Sheng Ding |
Basic Biology IV |
A new paradigm of lineage-specific reprogramming |
$1,568,395 |
Stanford University |
Gerald Crabtree |
Basic Biology IV |
Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch |
$1,392,150 |
University of California, Los Angeles |
Owen Witte |
Basic Biology IV |
Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells |
$1,254,960 |
University of California, San Diego |
Ananda Goldrath |
Basic Biology IV |
Mechanisms to protect hESC-derived cells from allogenic immune rejection |
$1,160,997 |
University of California, San Diego |
David Traver |
Basic Biology IV |
DECIPHERING THE INSTRUCTIONS FOR VERTEBRATE HSC SPECIFICATION AND AMPLIFICATION. |
$1,363,698 |
Stanford University |
Roel Nusse |
Basic Biology IV |
Asymmetric stem cell division oriented by a local self-renewing signal |
$1,038,600 |
Stanford University |
Michelle Monje |
Basic Biology IV |
Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain |
$1,264,248 |
University of California, San Diego |
Eugene Yeo |
Basic Biology IV |
Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration |
$1,260,360 |
Cedars-Sinai Medical Center |
Eduardo Marbán |
Basic Biology IV |
Mechanism of heart regeneration by cardiosphere-derived cells |
$1,367,604 |
University of California, San Francisco |
Barbara Panning |
Basic Biology IV |
Investigation of the role of O-GlcNAcylation in SOX2 function during reprogramming |
$1,260,037 |
University of California, Berkeley |
Robert Tjian |
Basic Biology IV |
Transcriptional regulation of pluripotency in human embryonic stem cells |
$1,220,968 |
Stanford University |
Anne Brunet |
Basic Biology IV |
Energy metabolism and aging pathways in human stem cell reprogramming and differentiation |
$1,414,044 |
Stanford University |
Joseph Wu |
Disease Team Therapy Development - Research |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$19,060,330 |
University of Southern California |
Andrew McMahon |
Research Leadership |
Repair and regeneration of the nephron |
$5,672,206 |
Stanford University |
Judith Shizuru |
Disease Team Therapy Development - Research |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$18,990,683 |
University of California, Los Angeles |
Antoni Ribas |
Disease Team Therapy Development - Research |
Genetic Re-programming of Stem Cells to Fight Cancer |
$14,144,221 |
University of California, Davis |
John Laird |
Disease Team Therapy Development - Research |
Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia |
$3,728,384 |
University of California, Davis |
Nancy Lane |
Disease Team Therapy Development - Research |
Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells |
$18,231,356 |
University of California, Davis |
Vicki Wheelock |
Disease Team Therapy Development - Research |
MSC engineered to produce BDNF for the treatment of Huntington's disease |
$8,924,235 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Disease Team Therapy Development - Research |
Progenitor Cells Secreting GDNF for the Treatment of ALS |
$16,168,464 |
University of California, Los Angeles |
Stanley Nelson |
Early Translational from Disease Team Conversion |
Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$1,823,545 |
StemCells, Inc. |
Alexandra Capela |
Disease Team Therapy Development - Research |
Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy |
$8,901,641 |
Capricor, Inc |
Rachel Smith |
Disease Team Therapy Development - Research |
Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction |
$14,405,857 |
University of California, Irvine |
Henry Klassen |
Disease Team Therapy Development - Research |
Retinal progenitor cells for treatment of retinitis pigmentosa |
$17,144,825 |
University of California, San Francisco |
Holger Willenbring |
Early Translational III |
Generation of safe and therapeutically effective human induced hepatocyte-like cells |
$1,544,170 |
University of California, San Francisco |
Morton Cowan |
Early Translational III |
Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID |
$3,862,367 |
Gladstone Institutes, J. David |
Deepak Srivastava |
Early Translational III |
Direct Cardiac Reprogramming for Heart Regeneration |
$5,795,871 |
University of California, Davis |
Kyriacos Athanasiou |
Early Translational III |
Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells |
$1,735,703 |
City of Hope, Beckman Research Institute |
Stephen Forman |
Early Translational III |
Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells |
$5,215,447 |
Scripps Research Institute |
Peter Schultz |
Early Translational III |
Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis |
$2,559,333 |
Stanford University |
Joseph Wu |
Early Translational III |
Heart Repair with Human Tissue Engineered Myocardium |
$4,395,080 |
Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Early Translational III |
Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
University of California, Irvine |
Craig Walsh |
Early Translational III |
Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells |
$4,535,005 |
University of California, San Diego |
Mark Tuszynski |
Early Translational III |
Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury |
$4,600,447 |
University of California, San Diego |
Eugene Yeo |
Early Translational III |
Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons |
$1,532,323 |
Salk Institute for Biological Studies |
David Schubert |
Early Translational III |
Stem cell based small molecule therapy for Alzheimer's disease |
$1,673,757 |
Stanford University |
Helen Blau |
Early Translational III |
Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients |
$1,825,283 |
University of California, Davis |
Walter Boyd |
Early Translational III |
Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair |
$4,631,754 |
University of California, San Diego |
Eric Adler |
Early Translational III |
Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease |
$1,701,575 |
University of Southern California |
Toshio Miki |
Early Translational III |
Generation of hepatic cell from placental stem cell for congenital metabolic disorders |
$1,750,375 |
University of California, San Francisco |
Arnold Kriegstein |
Early Translational III |
Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury |
$1,623,251 |
Stanford University |
Bertha Chen |
Early Translational III |
Autologous iPSC Therapy for Urinary Incontinence |
$4,715,738 |
University of California, San Diego |
Lawrence Goldstein |
Early Translational III |
Identifying Drugs for Alzheimer's Disease with Human Neurons Made From Human IPS cells |
$1,774,420 |
Children's Hospital of Orange County |
Philip Schwartz |
Early Translational III |
Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease |
$4,266,015 |
University of California, San Diego |
Yang Xu |
Early Translational III |
Human ES cell based therapy of heart failure without allogenic immune rejection |
$1,857,600 |
University of Southern California |
Kathy Rich |
Conference |
The Stem Cell Niche in Development and Regeneration |
$7,476 |
University of California, Berkeley |
Song Li |
Conference |
University of California Systemwide Bioengineering Symposium 2012 |
$25,200 |
Cedars-Sinai Medical Center |
Clive Svendsen |
iPSC Consortia Award |
The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development |
$300,000 |
Scripps Research Institute |
James Williamson |
Creativity Awards |
Stem Cell Summer Academy: Creating the Next Generation of Scientists |
$205,122 |
University of California, San Francisco |
Katherine Nielsen |
Creativity Awards |
UCSF SEP High School Intern Program |
$168,947 |
University of California, Davis |
Gerhard Bauer |
Creativity Awards |
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$250,064 |
City of Hope, Beckman Research Institute |
Paul Salvaterra |
Creativity Awards |
Creativity Award Program in Stem Cell Biology for California High School Students |
$260,825 |
Gladstone Institutes, J. David |
Shannon Noonan |
Creativity Awards |
Gladstone Summer Scholars (GSS) internship program |
$35,044 |
University of Southern California |
Roberta Brinton |
Creativity Awards |
CIRM STAR High School Summer Research and Creativity Program |
$271,160 |
University of California, Santa Barbara |
Lina Kim |
Creativity Awards |
Research Mentorship Program-Immersing High School Students in College Research |
$280,726 |
Stanford University |
Paul Utz |
Creativity Awards |
SIMR Program: Stem Cell & Developmental Biology Research Internships |
$340,611 |